BD announced that the FDA has approved the first drug to be offered in the just-launched BD Simplist ready-to-administer, line of prefilled generic injectables.
For a traditional vial and syringe injection sequence, clinicians perform up to 20 steps, which may increase the potential risk for error. BD Simplist prefilled injectables reduce the sequence to approximately 12 steps. These ready-to-use syringes are individually packaged and are barcoded for easy identification.
Diphenhydramine HCl Injection will be the first drug to be offered in the BD Simplist line. It will be available as a 50mg/mL strength in a 1mL prefilled single-use syringe in a 24-count carton. BD Simplist prefilled injectables will be commercialized and manufactured by BD Rx Inc. BD Rx plans to launch 20–30 prefilled injectables over the next few years.
For more information call (866) 943-8534 or visit www.bdrxinc.com.